Patients with pulmonary hypertension (PH) experience distressing symptoms that can undermine quality of life (QoL) and treatment adherence. Complementary health approaches are known to help manage symptoms of chronic conditions and may have therapeutic benefits in PH.
Objective:
To explore the impact of Urban Zen Integrative Therapy (UZIT) on PH-related symptoms.
Design:
A within-subjects, pre-/post-intervention, repeated-measures design.
Subjects/Setting:
Community-dwelling adults with PH received weekly UZIT sessions in an outpatient setting.
Measurements:
Participants (n = 14) rated symptoms before and after each session and before and after the six-week UZIT program. Mixed-effects modeling with repeated measures was used to estimate differences in mean symptom scores before and after individual sessions. Cohen's d effect sizes were used to evaluate the impact of the UZIT program on symptoms.
Results:
Mean scores for pain (F(1, 105) = 19.99, p < 0.001), anxiety (F(1, 96) = 24.64, p < 0.001), fatigue (F(1, 120) = 15.68, p < 0.001), and dyspnea (F(1, 68) = 16.69, p < 0.001) were significantly reduced after UZIT sessions. Effects were moderate to large for symptom severity (d = 0.59–1.32) and moderate for symptom burden (d = 0.56) and fatigue (d = 0.62), and small for QoL (d = 0.33) after the six-week UZIT program.
Conclusions:
Individualized UZIT sessions were associated with reductions in symptom severity for pain, anxiety, fatigue, and dyspnea. The six-week UZIT program was associated with improvements in symptom burden, activity limitation, and QoL.
ClinicalTrial.gov no.:
NCT03194438
Get full access to this article
View all access options for this article.
References
1.
TaichmanDB, ShinJ, HudL, et al.: Health-related quality of life in patients with pulmonary arterial hypertension. Resp Res, 2005; 6:92.
2.
MaturaLA, McDonoughA, HanlonAL, CarrollDL: Development and initial psychometric properties of the pulmonary arterial hypertension symptom scale (PAHSS). Appl Nurs Res, 2015; 28:42–47.
3.
McCollisterDH, BeutzM, McLaughlinV, et al.: Depressive symptoms in pulmonary arterial hypertension: Prevalence and association with functional status. Psychosomatics, 2010; 51:339–339.e8.
4.
Von VisgerTT, KuntzKK, PhillipsGS, et al.: Depressive symptoms in pulmonary arterial hypertension: Prevalence and association with functional status. Heart Lung, 2018; 47:115–121.
DrewBL, MotterT, RossR, et al.: Care for the caregiver: Evaluation of mind-body self-care for accelerated nursing students. Holist Nurs Pract, 2016; 30:148–154.
7.
KliglerB, HomelP, HarrisonLB, et al.: Impact of the Urban Zen Initiative on patients' experience of admission to an inpatient oncology floor: A mixed-methods analysis. J Altern Complement Med, 2011; 17:729–734.
McLaughlinVV, ArcherSL, BadeschDB, et al.: ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.,; and the Pulmonary Hypertension Association. J Am Coll Cardiol, 2009; 53:1573–1619.
Von VisgerT, ThraneS, KlattM, et al.: Intervention fidelity monitoring of Urban Zen Integrative Therapy (UZIT) for persons with pulmonary hypertension. J Complement Ther Med, 2019; 45:45–49.
12.
WyattG, SikorskiiA, RahbarMH, et al.: Intervention fidelity: Aspects of complementary and alternative medicine research. Cancer Nurs, 2010; 33:331–342.
Galen Research/Papworth Hospital: CAMPHOR manual for users. 2005.
17.
BenzaRL, MillerDP, Gomberg-MaitlandM, et al.: Predicting survival in pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation, 2010; 122:164–172.
18.
MaturaLA, McDonoughA, CarrollDL: Symptom prevalence, symptom severity, and health-related quality of life among young, middle, and older adults with pulmonary arterial hypertension. Am J Hosp Palliat Care, 2016; 33:214–221.
19.
HighlandKB, SchoomakerA, RojasW, et al.: Benefits of the restorative exercise and strength training for operational resilience and excellence yoga program for chronic low back pain in service members: A pilot randomized controlled trial. Arch Phys Med Rehabil, 2018; 99:91–98.
20.
JorgeMP, SantaellaDF, PontesIM, et al.: Hatha yoga practice decreases menopause symptoms and improves quality of life: A randomized controlled trial. Complement Ther Med, 2016; 26:128–135.
21.
Ben-JosefAM, ChenJ, WileytoP, et al.: Effect of eischens yoga during radiation therapy on prostate cancer patient symptoms and quality of life: A randomized phase II trial. Int J Radiat Oncol Biol Phys, 2017; 98:1036–1044.
22.
Kenne SarenmalmE, MartenssonLB, AnderssonBA, et al.: Mindfulness and its efficacy for psychological and biological responses in women with breast cancer. Cancer Med, 2017; 6:1108–1122.
23.
LengacherCA, ReichRR, PatersonCL, et al.: Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors: A randomized controlled trial. J Clin Oncol, 2016; 34:2827–2834.
24.
ReichRR, LengacherCA, AlinatCB, et al.: Mindfulness-based stress reduction in post-treatment breast cancer patients: Immediate and sustained effects across multiple symptom clusters. J Pain Symptom Manage, 2017; 53:85–95.
25.
CramerH, LaucheR, KloseP, et al.: Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. Cochrane Database Syst Rev, 2017; 1:CD010802.
26.
JohnsSA, BrownLF, Beck-CoonK, et al.: Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors. Support Care Cancer, 2016; 24:4085–4096.
27.
BijurPE, SilverW, GallagherEJ: Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med, 2001; 8:1153–1157.
28.
HawkerGA, MianS, KendzerskaT, FrenchM: Measures of adult pain: Visual analog scale for pain (VAS pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res, 2011; 63(S11):S240–S252.
29.
AhlersSJ, van GulikL, van der VeenAM, et al.: Comparison of different pain scoring systems in critically ill patients in a general ICU. Crit Care, 2008; 12:R15.
30.
ChlanLL: Relationship between two anxiety instruments in patients receiving mechanical ventilatory support. J Adv Nurs, 2004; 48:493–499.
31.
ChlanLL, SavikK: Contributors to fatigue in patients receiving mechanical ventilatory support: A descriptive correlational study. Intensive Crit Care Nurs, 2015; 31:303–308.
32.
ElliottD: Comparison of three instruments for measuring patient anxiety in a coronary care unit. Intensive Crit Care Nurs, 1993; 9:195–200.
33.
LeeKA, HicksG, Nino-MurciaG: Validity and reliability of a scale to assess fatigue. Psychiatry Res, 1991; 36:291–298.
34.
BrunierG, GraydonJ: A comparison of two methods of measuring fatigue in patients on chronic haemodialysis: Visual analogue vs likert scale. Int J Nurs Stud, 1996; 33:338–348.
35.
KendrickKR, BaxiSC, SmithRM: Usefulness of the modified 0–10 borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs, 2000; 26:216–222.
36.
MadorMJ, RodisA, MagalangUJ: Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest, 1995; 107:1590–1597.
37.
WilsonRC, JonesPW: A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond), 1989; 76:277–282.
38.
WilsonRC, JonesPW: Long-term reproducibility of Borg scale estimates of breathlessness during exercise. Clin Sci (Lond), 1991; 80:309–312.
39.
MaturaLA, McDonoughA, HanlonAZ, et al.: Development and Psychometric properties of the pulmonary arterial hypertension symptom scale (PAHSS). Appl Nurs Res, 2015; 28:42–47.
40.
McKennaSP, RatcliffeJ, MeadsDM, BrazierJE: Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses. Health Qual Life Outcomes, 2008; 6:65.
41.
MeadsDM, McKennaSP, DoughtyN, et al.: The responsiveness and validity of the CAMPHOR utility index. Euro Resp J, 2008; 32:1513–1519.
42.
GrantS, Mayo-WilsonE, MontgomeryP, et al.: CONSORT-SPI 2018 explanation and elaboration: Guidance for reporting social and psychological intervention trials. Trials, 2018; 19:406.
